A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences (Q42497579)

1 November 2017

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences (English)

1 reference

1 November 2017

0 references

1 reference

1

1 reference

1 November 2017

14

Marcella Mottolese

0 references

Valerie Speirs

24

Valerie Speirs

0 references

Andrew M. Hanby

23

Andrew M Hanby

1 reference

Rebecca A Millican-Slater

1 November 2017

Rebecca A Brannan

3

0 references

Maria Litwiniuk

Maria Litwiniuk

13

0 references

Philip R Quinlan

Philip R Quinlan

17

0 references

author name string

Graham R Ball

2

1 reference

1 November 2017

Gabor Cserni

4

1 reference

1 November 2017

Anna Di Benedetto

5

1 reference

1 November 2017

Jo Dent

6

1 reference

1 November 2017

Laura Fulford

7

1 reference

1 November 2017

Helen Honarpisheh

8

1 reference

1 November 2017

Lee Jordan

9

1 reference

1 November 2017

J Louise Jones

10

1 reference

1 November 2017

Rani Kanthan

11

1 reference

1 November 2017

Loaie Maraqa

12

1 reference

1 November 2017

Marcella Mottolese

14

1 reference

1 November 2017

Steven Pollock

15

1 reference

1 November 2017

Elena Provenzano

16

1 reference

1 November 2017

Georgina Reall

18

1 reference

1 November 2017

Sami Shousha

19

1 reference

1 November 2017

Mark Stephens

20

1 reference

1 November 2017

Eldo T Verghese

21

1 reference

1 November 2017

Rosemary A Walker

22

1 reference

1 November 2017

language of work or name

English

0 references

publication date

18 November 2011

1 reference

Breast Cancer Research and Treatment

1 November 2017

1 reference

1 November 2017

133

1 reference

1 November 2017

3

1 reference

1 November 2017

949-958

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1856-9

1 November 2017

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Male breast cancer: a population-based comparison with female breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Breast carcinoma in men: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Male breast cancer: is the incidence increasing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Male breast carcinoma: increased awareness needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Immunohistochemical characterization of subtypes of male breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Molecular classification of breast carcinomas using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Cytokeratin profiles of male breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Molecular markers in male breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Prognostic factors in node-negative male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Androgen receptor expression in male breast carcinoma: lack of clinicopathological association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Status of HER-2 in male and female breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Her-2/neu gene amplification and protein expression in primary male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Is male breast cancer similar or different than female breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

The survival pattern in male breast cancer. An analysis of 1429 patients from the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Male breast cancer: a gender issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Current and emerging biomarkers in breast cancer: prognosis and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Expression of oestrogen receptor beta isoforms is regulated by transcriptional and post-transcriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Minireview: nuclear receptors and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Steroid hormone receptor expression in male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

The androgen receptor in breast cancer: learning from the past.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Influence of sex hormones on cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Multidisciplinary meeting on male breast cancer: summary and research recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

MicroRNA expression profiling of male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Identification of differentially expressed microRNAs in human male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1856-9

10.1007/S10549-011-1856-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference